PTGX
Protagonist Therapeutics, Inc
+0.84 (+0.59%)143.68USD137K成交股數9.3B市值139.5本益比(近四季)33.0股價營收比+3749.2%營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 213M+3749% | 56.4M+99% | 7.4M+59% | 4.7M+13% | 5.5M-98% | 28.3M-53% | 4.7M | 4.2M | 255M | 60.0M | 0.00 | 0.00 |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 42.1M | 46.7M | 46.4M | 40.0M | 37.0M | 35.9M | 36.0M | 33.5M | 33.7M | 28.9M | 30.7M | 33.2M |
| 銷售管理費用 | 12.6M | 13.3M | 11.4M | 11.1M | 10.6M | 11.7M | 10.2M | 9.4M | 14.9M | 8.1M | 7.7M | 9.2M |
| 營業利益 | 159M-478% | −3.6M-81% | −50.4M+21% | −46.4M+20% | −42.0M-120% | −19.3M-184% | −41.5M+8% | −38.8M-8% | 206M | 23.0M | −38.3M | −42.4M |
| 營業利益率 | 74.4% | -6.5% | -677.1% | -985.2% | -758.0% | -68.2% | -886.7% | -931.0% | 80.9% | 38.4% | – | – |
| 稅後淨利 | 163M-568% | 3.8M-132% | −44.4M+34% | −39.3M+28% | −34.8M-117% | −11.7M-143% | −33.2M-3% | −30.6M-20% | 207M | 27.3M | −34.1M | −38.5M |
| 淨利率 | 76.3% | 6.7% | -596.8% | -834.9% | -627.0% | -41.2% | -710.4% | -734.7% | 81.3% | 45.6% | – | – |
| 稀釋 EPS | 2.29-516% | 0.05-126% | -0.69+28% | -0.62+24% | -0.55-117% | -0.19-135% | -0.54-7% | -0.50-26% | 3.26 | 0.54 | -0.58 | -0.68 |
| 稀釋股數 | 71.0M | 70.5M | 63.6M | 63.8M | 63.5M | 63.0M | 61.8M | 61.3M | 63.6M | 56.8M | 59.2M | 56.8M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 420M | 194M | 128M | 114M | 169M | 140M | 131M | 356M | 173M | 187M | 231M | 235M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 886M | 697M | 668M | 702M | 718M | 742M | 604M | 615M | 629M | 358M | 330M | 320M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 44.0M | 42.0M | 53.5M | 56.3M | 50.0M | 53.1M | 71.9M | 73.3M | 68.8M | 21.3M | 27.9M | 26.4M |
| 股東權益 | 842M | 655M | 615M | 645M | 668M | 689M | 532M | 541M | 560M | 337M | 302M | 294M |
| 負債比 | 5.0% | 6.0% | 8.0% | 8.0% | 7.0% | 7.2% | 11.9% | 11.9% | 10.9% | 5.9% | 8.4% | 8.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −48.9M-139% | – | – | – | 125M | – | – | −27.4M | – | – | – |
| 資本支出 | – | 215K | – | – | – | 545K | – | – | 242K | – | – | – |
| 自由現金流 | – | −49.2M-139% | – | – | – | 125M | – | – | −27.7M | – | – | – |
| 折舊攤銷 | – | 407K | – | – | – | 239K | – | – | 236K | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -87.2% | – | – | – | 440.7% | – | – | -10.9% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 46.0M
| Single Reportable | 46.0M | 100.0% | -89.4% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 46.0M | -89.4% | −130M | -282.8% | -2.05 | 56.1M |
| FY2024 | 434M | +624.1% | 275M | 63.3% | 4.23 | 183M |
| FY2023 | 60.0M | +125.7% | −79.0M | -131.6% | -1.39 | −70.8M |
| FY2022 | 26.6M | -2.8% | −127M | -479.3% | -2.60 | −109M |
| FY2021 | 27.4M | -4.4% | −126M | -458.9% | -2.71 | −109M |
| FY2020 | 28.6M | +12293.1% | −66.2M | -231.1% | -1.92 | −73.0M |
| FY2019 | 231K | -99.3% | −77.2M | -33,414.3% | -2.98 | −42.5M |
| FY2018 | 30.9M | – | −38.9M | -125.9% | -1.74 | −50.4M |